Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06378632Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Role: lead

NCT05876533Active Not Recruiting

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

Role: lead

NCT04325048Completed

Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients

Role: lead

NCT03438799Unknown

COMMUNITY STUDY- A Study to Collect Information for the Cordio System

Role: lead

NCT03714126Completed

Remote Speech Analysis in HF Patients Undergoing Haemodialysis

Role: lead

NCT03266029Completed

Clinical Evaluation of Cordio App in Adult ADHF Patients

Role: lead

All 6 trials loaded